MIAMI, Feb. 04, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that, subject to market and other conditions, it intends to offer $200 million aggregate principal amount of Convertible Senior Notes due 2025 (the “Notes”) in an underwritten public offering. The Notes will be general senior unsecured obligations of the Company, will pay interest semiannually in arrears and will be convertible into, at the Company’s election, cash, shares of the Company’s common stock, or a combination of cash and common stock, as further described in the prospectus supplement. The Company intends to grant the underwriter an option to purchase up to an additional $30 million aggregate principal amount of the Notes to cover over-allotments, if any.
